Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
IMUX
IMUX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
IMUX News
Immunic, Inc. Engages in Key Conferences
Jun 10 2026
PRnewswire
Immunic to Participate in Multiple Conferences
Jun 10 2026
Newsfilter
Immunic Presents New Data Highlighting Efficacy of Vidofludimus Calcium
May 28 2026
PRnewswire
Immunic Presents New Data Highlighting Efficacy of Vidofludimus Calcium
May 28 2026
Newsfilter
Immunic Appoints Erik Lundgren as CEO Effective May 2026
May 27 2026
seekingalpha
Immunic Appoints New CEO to Drive Growth
May 27 2026
PRnewswire
Immunic Appoints New CEO to Drive Growth
May 27 2026
Newsfilter
Immunic Appoints New Chair of Board of Directors
May 19 2026
PRnewswire
Immunic Appoints New Chair of Board
May 19 2026
Newsfilter
Immunic Q1 Earnings Miss Expectations with EPS of -$1.08
May 13 2026
seekingalpha
Immunic Appoints New CMO and Raises $200 Million in Financing
May 13 2026
PRnewswire
Immunic Appoints New CMO and Raises $200 Million
May 13 2026
Newsfilter
Immunic, Inc. to Participate in Investor Conferences
Apr 30 2026
PRnewswire
Immunic to Participate in Key Investor Conferences
Apr 30 2026
Newsfilter
Immunic Appoints New Chief Medical Officer
Apr 28 2026
NASDAQ.COM
Immunic Appoints New Chief Medical Officer to Drive Neurology Drug Development
Apr 28 2026
PRnewswire
Show More News
